Kathleen Peterson

Kathleen Peterson

Cooley LLP

Contact  |  View Bio  |  RSS

Latest Publications

Share:

Phrma Challenges HRSA Interpretative Rule On Orphan Drugs In The 340B Drug Discount Program

On October 9, 2014, the Pharmaceutical Research & Manufacturers of America (“PhRMA”) filed a lawsuit seeking to enjoin the Health Resources Services Administration (“HRSA”) from implementing its July 23, 2014 “Interpretive...more

10/13/2014 - HRSA Orphan Drugs Pharmaceutical Manufacturers PHRMA Prescription Drugs Section 340B

Blog: 9th Circuit Upholds Alameda County Manufacturer-Funded Drug Disposal Ordinance

On September 30, 2014, the U.S. Court of Appeals for the 9th Circuit unanimously upheld a lower court’s finding that a California county ordinance requiring prescription drug manufacturers to operate and finance certain drug...more

10/9/2014

FDA Releases Five New Compounding Pharmacy Policy Documents

Yesterday, the U.S. Food and Drug Administration (FDA) released five documents outlining the FDA’s current policies regarding compounded drug products for human use. All of the documents are available through the FDA’s...more

7/3/2014 - DQSA Draft Guidance Drug Compounding FDA Final Guidance Pharmaceutical pharmacie Proposed Regulation

340B Drug Discount Program Orphan Drug Rule Vacated: ACA “New” Covered Entity Types No Longer Authorized to Purchase Orphan Drugs...

The D.C. District Court permanently enjoined the U.S. Department of Health & Human Services (HHS) Health Resources and Services Administration (HRSA) from implementing its July 23, 2013 final rule on “exclusion of Orphan...more

5/27/2014 - 340B Affordable Care Act Covered Entities FFDCA HHS HRSA Orphan Drugs Pharmaceutical Manufacturers

4 Results
|
View per page
Page: of 1